Literature DB >> 11012910

Mortality caused by sepsis in patients with end-stage renal disease compared with the general population.

M J Sarnak1, B L Jaber.   

Abstract

BACKGROUND: In the United States, infection is second to cardiovascular disease as the leading cause of death in patients with end-stage renal disease (ESRD), and septicemia accounts for more than 75% of this category. This increased susceptibility to infections is partly due to uremia, old age, and comorbid conditions. Although it is intuitive to believe that mortality caused by sepsis may be higher in patients with ESRD compared with the general population (GP), no such data are currently available.
METHODS: We compared annual mortality rates caused by sepsis in patients with ESRD (U.S. Health Care Financing Administration 2746 death notification form) with those in the GP (death certificate). Data were abstracted from the U.S. Renal Data System (1994 through 1996 Special Data request) and the National Center for Health Statistics. Data were stratified by age, gender, race, and diabetes mellitus (DM). Sensitivity analyses were performed to account for potential limitations of the data sources.
RESULTS: Overall, the annual percentage mortality secondary to sepsis was approximately 100- to 300-fold higher in dialysis patients and 20-fold higher in renal transplant recipients (RTRs) compared with the GP. Mortality caused by sepsis was higher among diabetic patients across all populations. After stratification for age, differences between groups decreased but retained their magnitude. These findings remained robust despite a wide range of sensitivity analyses. Indeed, mortality secondary to sepsis remained approximately 50-fold higher in dialysis patients compared with the GP, using multiple cause-of-death analyses; was approximately 50-fold higher in diabetic patients with ESRD compared with diabetic patients in the GP, when accounting for underreporting of DM on death certificates in the GP; and was approximately 30-fold higher in RTRs compared with the GP, when accounting for the incomplete ascertainment of cause of death among RTRs. Furthermore, despite assignment of primary cause-of-death to major organ infections in the GP, annual mortality secondary to sepsis remained 30- to 45-fold higher in the dialysis population.
CONCLUSIONS: Patients with ESRD treated by dialysis have higher annual mortality rates caused by sepsis compared with the GP, even after stratification for age, race, and DM. Consequently, this patient population should be considered at high-risk for the development of lethal sepsis.

Entities:  

Mesh:

Year:  2000        PMID: 11012910     DOI: 10.1111/j.1523-1755.2000.00337.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  201 in total

1.  Evaluation of hypophosphatemia: lessons from patients with genetic disorders.

Authors:  Justine Bacchetta; Isidro B Salusky
Journal:  Am J Kidney Dis       Date:  2011-11-09       Impact factor: 8.860

2.  Cardiac implantable electronic devices in end-stage renal disease patients: preservation of central venous circulation.

Authors:  Gustavo Lopera; Gerald A Beathard; Jose Exaire; Roger Carrillo
Journal:  J Interv Card Electrophysiol       Date:  2012-06       Impact factor: 1.900

3.  Sepsis and AKI: more complex than just a simple question of chicken and egg.

Authors:  P M Honoré; R Jacobs; W Boer; O Joannes-Boyau
Journal:  Intensive Care Med       Date:  2010-12-09       Impact factor: 17.440

4.  Iron sucrose impairs phagocytic function and promotes apoptosis in polymorphonuclear leukocytes.

Authors:  Hirohito Ichii; Yuichi Masuda; Tania Hassanzadeh; Mateen Saffarian; Sastry Gollapudi; Nosratola D Vaziri
Journal:  Am J Nephrol       Date:  2012-06-19       Impact factor: 3.754

5.  Influence of diabetes on endothelial cell response during sepsis.

Authors:  P Schuetz; K Yano; M Sorasaki; L Ngo; M St Hilaire; J M Lucas; W Aird; N I Shapiro
Journal:  Diabetologia       Date:  2011-02-01       Impact factor: 10.122

6.  Acute kidney injury as an independent predictor of infection and malignancy: the NARA-AKI cohort study.

Authors:  Miho Tagawa; Masatoshi Nishimoto; Maiko Kokubu; Masaru Matsui; Masahiro Eriguchi; Ken-Ichi Samejima; Yasuhiro Akai; Kazuhiko Tsuruya
Journal:  J Nephrol       Date:  2019-10-15       Impact factor: 3.902

7.  Secular Trends in Infection-Related Mortality after Kidney Transplantation.

Authors:  Susanna Kinnunen; Pauli Karhapää; Auni Juutilainen; Patrik Finne; Ilkka Helanterä
Journal:  Clin J Am Soc Nephrol       Date:  2018-04-05       Impact factor: 8.237

8.  Efficacy of a liver resection for hepatocellular carcinoma in patients with chronic renal failure.

Authors:  Takashi Orii; Tetsuro Takayama; Izumi Haga; Tatsuya Fukumori; Noritoshi Amada
Journal:  Surg Today       Date:  2008-03-27       Impact factor: 2.549

9.  Comparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccine Among Patients Receiving Maintenance Hemodialysis.

Authors:  Anne M Butler; J Bradley Layton; Vikas R Dharnidharka; John M Sahrmann; Marissa J Seamans; David J Weber; Leah J McGrath
Journal:  Am J Kidney Dis       Date:  2019-08-01       Impact factor: 8.860

10.  Association between proximity to the attending nephrologist and mortality among patients receiving hemodialysis.

Authors:  Marcello Tonelli; Braden Manns; Bruce Culleton; Scott Klarenbach; Brenda Hemmelgarn; Natasha Wiebe; John S Gill
Journal:  CMAJ       Date:  2007-10-23       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.